Gliprip-MV1 Tablet PR
By Gliprip-MV
Rx
10 Tablet PR in a Strip

Composition
Glimepiride(1mg) + Metformin(500mg) + Voglibose(0.2mg)

Manufacturer - Suraksha Pharma Pvt Ltd
33, jadugar road, niti nagar, civil lines, roorkee, uttarakhand 247667

Expires on or after
June, 2027

liver
When taking Gliprip-MV1 Tablet PR, be cautious if you have liver disease. It may be necessary to adjust the dose, so it's important to consult your doctor before using this medication. Typically, for patients with mild to moderate liver disease, Gliprip-MV1 Tablet PR is initially administered at a low dose. However, it is not advisable for individuals with severe liver disease to use this medication without proper medical guidance.

kidney
Gliprip-MV1 Tablet PR may be unsafe for patients with kidney disease. It is advised to avoid using this medication. Please consult your doctor before using Gliprip-MV1 Tablet PR, especially if you have severe kidney disease.

alcohol
It is not safe to drink alcohol while taking Gliprip-MV1 Tablet PR. Please avoid consuming alcohol to prevent any potential risks or complications.

driving
When your blood sugar levels are too low or too high, it can affect your ability to drive safely. If you experience these symptoms, avoid driving while taking Gliprip-MV1 Tablet PR.

pregnancy
Gliprip-MV1 Tablet PR may be unsafe during pregnancy. Animal studies suggest potential harm to the baby. Consult your doctor for a thorough evaluation of benefits and risks before using this medication.

breastfeeding
It is not recommended to use Gliprip-MV1 Tablet PR while breastfeeding as it may pass into breastmilk and be harmful to the baby.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | ANTI DIABETIC |
| Action Class | - |
₹74.59
₹87.75
15% OFF
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024
